Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

What can biomarkers tell us about cognition in Parkinson's disease?

Movement disorders : official journal of the Movement Disorder Society - 15 Apr 2014

Mollenhauer Brit, Rochester Lynn, Chen-Plotkin Alice, Brooks David

Abstract excerpt

Cognitive decline is common in Parkinson's disease (PD), even in the early motor stage, and this non-motor feature impacts quality of life and prognosis tremendously. In this article, we discuss marker candidates for cognitive decline in PD from different angles, including functional and structural imaging techniques, biological fluid markers in cerebrospinal fluid, and blood genetic predictors, as well as gait...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Cognition
Share to Cognition Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COMT gene

Share to MAPT gene

Share to Genetic Variation

Share to Parkinson Disease

Source

Open in PubMed Open full text

Identifiers

PMID: 24757111
DOI: 10.1002/mds.25846
PMCID: PMC4384332

Genes

APOE
COMT
MAPT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

What can biomarkers tell us about cognition in Parkinson's disease?PMID 24757111Read ↗

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.Semantic proximity Read ↗

Parkinson's disease--the continuing search for biomarkers.Semantic proximity Read ↗

Genetic influences on cognitive decline in Parkinson's disease.Semantic proximity Read ↗

APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.Semantic proximity Read ↗

Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature.Semantic proximity Read ↗

Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson's disease.Semantic proximity Read ↗

Cognitive impairment in Parkinson's disease.Semantic proximity Read ↗

Alpha-Synuclein and Cognitive Decline in Parkinson DiseaseSemantic proximity Read ↗

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s diseaseSemantic proximity Read ↗

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.Semantic proximity Read ↗

Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease.Semantic proximity Read ↗

Cerebrospinal fluid biomarker for Parkinson's disease: An overviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.